Bowel Cancer Foundation Trust Blog

FDA approves AI tech for colonoscopy accuracy

Apr 15, 2021

The FDA has approved an Artificial Intelligence device to detect sins of bowel cancer during colonoscopy.

Waikato DHB joins National Bowel Screening Programme

Mar 03, 2021

Waikato is the 15th DHB to join the National Bowel Screening Programme expecting to find up to 80 cancers in the Waikato region a year.

Nitrates in water increases bowel cancer risk

Feb 22, 2021

The Ministry of Health is due to set up a task force to look at the link between the levels of nitrates and bowel cancer that could save up to 50 people a year .

Guardant Health Launches Liquid Biopsy Test for bowel cancer patients

Feb 17, 2021

Guardant Reveal™ is a new US blood-only test able to detect, with 7-day turnaround time, residual disease after surgery and recurrence months earlier than current standard-of-care methods.

A camera in your toilet could help spot bowel cancer

Feb 15, 2021

A high-tech UK camera that clips onto the loo could speed up the detection of bowel cancer.

Bowel cancer ambassador angered by emergency department treatment

Feb 02, 2021

An ambassador for the Bowel Cancer Foundation Trust says staff at Christchurch Hospital’s emergency department (ED) need to lift their game after being told he was not an emergency.

Survival rates up, but inequities persist

Feb 02, 2021

While more and more kiwis are surviving longer with cancer the NZ medical system is not keeping up!

Thank you for helping us to achieve our biggest year

Dec 21, 2020

We raised over $1.1 million enabling us to create two world class research programmes, give help to the disability community and help improve access to cancer treatments across New Zealand.

Auckland DHB joins National Bowel Screening programme

Dec 07, 2020

Auckland District Health Board is the latest to join the National Bowel Screening Programme

3D printers can now print cancer cells to help fast track treatment

Dec 01, 2020

New 3D printing technology is being used to print cancer cells to personalise and fast track treatment.